GeneTex中国官方网站
  • China
寨卡病毒研究

寨卡病毒研究

Zika virus
 

Product Highlights

Validated by WB on lysate from Zika virus-infected cells.
Appear to distinguish between Zika, Dengue, and Chikungunya virus via IFA.
An extensive line of research antibodies against different Zika virus proteins.
 
Zika virus (ZIKV) exploded into international prominence in 2015. This mosquito-borne flavivirus had its first reported outbreak in 2007, followed by a larger event in 2013 in French Polynesia and the present outbreak in Brazil. Nearly 70 countries and territories have documented ZIKV transmission since 2007.
 
While about 80% of ZIKV infections are asymptomatic, the virus can cause influenza-like symptoms and other clinical manifestations including conjunctivitis. Infection has been linked to cases of neurological disease, including Guillain-Barre syndrome. Most concerning is the increasingly robust evidence associating ZIKV with microcephaly (and other neurodevelopmental problems) in newborns from infected mothers. ZIKV infection is diagnosed by serological, cytokine profiling, and RT-PCR testing. The serological assays can be cumbersome and can fail to clearly identify ZIKV in the presence of Dengue or other flaviviruses, so RT-PCR is the most reliable method to specifically detect the virus. However, antibodies targeting different protein components of ZIKV would be immensely useful to facilitate both basic research and as potential diagnostic reagents.
 
GeneTex is proud to offer an extensive line of research antibodies to support the study of Zika virus. Please see the highlighted products below or click the button to view the full list of GeneTex antibodies against Zika virus proteins.
 
 
See Products

Zika virus Capsid antibody (GTX133317)

Zika virus PrM antibody (GTX133305)

Zika virus E antibody (GTX133314)

 

Zika virus NS2B antibody (GTX133308)

Zika virus NS3 antibody (GTX133309)

Zika virus NS4B antibody (GTX133311)

 

Zika virus PrM antibody (GTX133305)

Zika virus E antibody (GTX133314)

Zika virus NS2B antibody (GTX133308)

 
Literature
SARS-CoV-2 (COVID-19) Research

小册 - SARS-CoV-2 (COVID-19) Research

下载 GeneTex 最新版本的 SARS-CoV-2 (COVID-19) Research 小册
Newsletter
IHC- and FCM-validated Antibodies for SARS-CoV-2 Research

IHC- and FCM-validated Antibodies for SARS-CoV-2 Research

IHC- and FCM-validated Antibodies for SARS-CoV-2 Research
Newsletter
新冠肺炎中和性抗体与病毒结合位的结构解析

新冠肺炎中和性抗体与病毒结合位的结构解析

新冠肺炎中和性抗体与病毒结合位的结构解析
Newsletter
COVID-19

新冠病毒抗体来了!

GeneTex分析抗原序列与抗原特性,率先与合作实验室完成测试,GTX632604抗体可于western blot实验下, 辨识新冠病毒的刺突蛋白
Articles
五大验证策略

五大验证策略

GeneTex employs various analytic validation strategies to ensure both consistent quality and specificity.
Newsletter

科学家对抗严重急性呼吸综合征冠状病毒2

严重急性呼吸综合征冠状病毒2与历史上流行过的严重急性呼吸综合征(SARS)和中东呼吸综合征(MERS)同为冠状病毒类,了解病毒的结合受体与交互作用方式,将有助于严重急性呼吸综合征冠状病毒2的药物开发。
Newsletter

从禽流感看细胞因子风暴

近期欧洲与亚洲多处爆发了高致病性的禽流感疫情,主要是由H5N1, H5N6与H5N8亚型的A型流感病毒所引起,导致多数禽类死亡,除了对经济影响重大,也存在感染人体的可能风险。
Newsletter

「胶」你怎么做!Western blot省时小密技

Articles

新冠肺炎快速检测试剂运作剖析

Promotion
GeneTex 抗体百元试用计划 - 体验质量 试用启航

GeneTex 抗体百元试用计划 - 体验质量 试用启航

Newsletter
HBV

Adoptive T cell therapy shows potential to eliminate hepatitis B virus (HBV) infection.

Is a cure for chronic hepatitis B on the horizon? Adoptive T cell therapy shows potential to eliminate hepatitis B virus (HBV) infection.
Literature
验证抗体精选

手册 - 抗体精选

下载 GeneTex 最新版本的抗体精选手册
Literature

折页 - 热门产品

下载 GeneTex 最新版本的热门产品折页
Literature
文献支持抗体

折页 - 文献支持抗体

下载 GeneTex 最新版本的文献支持抗体折页
Literature
病毒

折页 - 病毒

下载GeneTex最新版本的病毒折页
Literature
SARS-CoV-2 (COVID-19) Research

小册 - SARS-CoV-2 (COVID-19) Research

下载 GeneTex 最新版本的 SARS-CoV-2 (COVID-19) Research 小册
Literature
验证抗体精选

手册 - 抗体精选

下载 GeneTex 最新版本的抗体精选手册
Literature

折页 - 热门产品

下载 GeneTex 最新版本的热门产品折页
Literature
文献支持抗体

折页 - 文献支持抗体

下载 GeneTex 最新版本的文献支持抗体折页
Literature
病毒

折页 - 病毒

下载GeneTex最新版本的病毒折页